Introduction
Graves' disease is associated with an increased somatic (1) as well as psychiatric co-morbidity (2) , with possible profound effects on the mental health. In fact, the majority of GD patients experience some psychiatric symptoms, such as anxiety, nervousness, irritability, anger and sadness, poor concentration, and sometimes even changes in personality (3, 4) . Quality of life impairments, as determined by disease-specific and generic health related quality of life instruments, persist also after therapy (5) . In GD patients with involvement of the eyes, which is clinically the most severe manifestation of hyperthyroidism (6) , studies have demonstrated a significantly reduced quality of life (7), increased psychosocial morbidity (8), and have also reported psychotic symptoms (9).
Moreover, GD patients, both with and without orbitopathy (10), have an increased risk of long-term sickness absence, work disability, unemployment, loss of labour market income, and receiving a disability pension (10-12).
In a recent study of the entire Danish population (13), we found an increased mortality in patients with a history of GD, compared to a matched control population, whether with (23%) or without orbitopathy (19%). The negative impact on quality of life with an increased somatic and psychiatric morbidity raises the question whether these patients could have an increased risk of unnatural death due to suicide, accidents or violence/homicide. As for suicides, this has previously been shown in other chronic diseases with major impact on quality of life, such as diabetes mellitus (14, 15) . However, little is known about unnatural deaths in GD and GO patients. To our knowledge, there is only one prior study on this subject, which found no significantly increased risk of suicide in hyperthyroid patients (16) 
Denmark's long tradition for storing information on its citizens in nation-wide registers (17) , provides a unique opportunity for large scale, population-based investigations. In this study we aimed to address i) the risk of unnatural death in GD overall compared to an adequately matched control population, ii) the risk of unnatural death in GD patients without and with GO separately, compared to their respective control populations.
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Materials and methods

Data sources
In this register-based cohort study, data were retrieved from the Danish health registers listed below. By means of a unique personal identification number, the registers were linked and information was recovered on an individual level.
The Danish Civil Registration System (DCRS) contains information on demographics, vital status, date of death and residence of all persons living or having lived in Denmark (18) . The Danish National Patient Registry (DNPR) holds information on all diagnoses given at all hospital in-and outpatient visits in Denmark (19) . Registration of diagnoses is based on the Danish edition of the International Classification of Diseases, using the 10 th revision (ICD-10) from 1994 and up until now. The DNPR has high validity, with misclassification of thyroid diagnoses occurring in less than 2% (20, 21) . The quality of data on psychiatric diagnoses, based on register-based information, has also been found to 
Study population
Admissions to hospital wards have been registered in the DNPR since 1977.
However, registration of outpatient visits did not start until 1995. The DNPrR, with information on prescriptions of drugs, was also first established in 1995. Since GD patients, as well as the majority of patients with psychiatric disorders, are often solely treated as outpatients, the start date for inclusion in this study was set to the year 1995.
Subjects with GD were defined by an ICD-10 code E050, in the DNPR. GOsubjects were retrieved from the subjects with GD, and defined by the ICD-10 codes H052
and/or H062. Control subjects were defined by lack of thyroid or orbitopathy related ICD- This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
10 codes in DNPR and no evidence of dispensed prescriptions of thyroid hormone or antithyroid drugs in the DNPrR. The first six months of 1995 were used as a washout period, to ensure inclusion of only incident cases. Therefore, all cases appearing with a thyroid diagnosis in this period were excluded from the study. We identified 32,426 individuals with GD, out of whom 28,461 had GD without orbitopathy, and 3965 had GO.
Each case was randomly matched for age and sex with four control subjects.
Mortality and manners of death.
Information on date and manner of death was obtained from the DRCD (23).
Manners of unnatural death were categorized into accidental, suicidal, violence/homicide, and unknown.
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(ATC: N05A), antidepressant (ATC: N06A) or anxiolytic (ATC: N05BA) medication in the DNPrR were classified as having had a pre-existing psychiatric morbidity.
Statistical analyses.
Group frequencies were compared with the Pearson 2 test or Fisher's exact test when one or more of the cells had an expected frequency of ≤5. Group means were compared by a t-test and group medians by the Mann-Whitney-test. Risk of unnatural death in GD overall, and GD and GO separately, was evaluated by Cox's proportional hazard model, and time since diagnosis was the underlying time variable. Hence, person years of follow-up were accumulated from the date of diagnosis, and terminated at the date of death, emigration, or end of follow-up (December 31, 2012), whichever came first.
The validity of the proportional hazards assumption was evaluated by inspection of Schoenfeld residuals versus follow-up time (no significant associations were found).
Significant differences were defined as a p-value < 0.05, using two-tailed tests. All analyses were conducted using STATA version 14.1 (2015; Stata Corporation, College Station, TX, USA).
Ethical considerations.
There was no patient involvement in the design or analysis of this study. The data used in the study are anonymized so that the identity of all patients remained unknown to the investigators, and the project has been approved by the Danish Data Protection Agency. Project number: 704047.
Results
The baseline characteristics of GD and GO cases, as well as their control subjects are summarized in table 1. Compared to their controls, both GD and GO subjects had a significantly higher pre-existing morbidity and shorter time of follow-up (P<0.001).
There was no significant difference in CS between GD and GO individuals (P=0.248), but the median age at time of diagnosis was higher in the GD-than in the GO-group (Table 1) .
The median time of follow-up was 7.9 years (range 0-17.5).
Risk and manners of unnatural death in GD overall (GD and GO).
There was a significantly higher overall incidence of unnatural deaths, and specifically of suicide and unknown manners of death in individuals with GD compared to This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
controls ( Table 2 ). The hazard ratios (HR) for the different manners of death (Table 3) showed an increased risk of unknown manners of death in GD, also after adjustment for 
Risk and manners of unnatural death in GD.
GD patients had a significantly higher overall incidence of unnatural deaths, and specifically of unknown manners of death, than their controls ( (Table 3) .
Risk and manners of unnatural death in GO.
GO individuals had a significantly higher overall incidence of unnatural deaths, and specifically of suicide, compared to controls ( Table 3) .
Discussion
In this large scale, population-and register-based, long-term follow-up study of more than 30,000 Danish patients with GD, we explored type and magnitude of unnatural deaths. The most striking finding was that of a 101% increased risk of death by unknown manners as compared to a sex and age matched control population. There was also a 43% increased risk of death from suicide. However, despite the huge numbers investigated, this increased risk was not with certainty statistically significant (P=0.053) after adjustment for pre-existing somatic and psychiatric morbidity. After subdivision according to presence of GO there was an excess mortality of 84% by unknown unnatural manners in individuals with GD, and an 171% increased risk of suicide in GO patients. Excess mortality from suicide, in this range or higher, has also been found in other autoimmune conditions such as type 1 diabetes (26), inflammatory bowel disease (27), and rheumatoid arthritis (28).
Having access to data on deaths from accidents, violence/homicide, and a group labeled This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
"unknown", we included these although the groups were small and the manners of death more uncertain. As in previous register-based studies from Denmark (29), we did not include death by accidents, violence/homicide, and unknown manners of death in the suicide category, as these cannot be classified as certain suicides. It could be speculated that these three groups, especially the unknown group also include some deaths from suicide. Clearly, if some of the deaths registered as unknown manners of death were due to suicides, the reported risk rates for suicides in this study would be even higher. Are our findings plausible? Pointing towards a biological mechanism, the development of mood disorders and suicide has been linked to inflammation caused by infection and/or autoimmunity (34-36). On top of that, it is currently accepted that morbidity, both before and after the diagnosis of GD, is increased (1). Moreover, although discussed until recently (32), it is beyond doubt that mortality is also increased (37), especially if the disease is poorly controlled (33). Furthermore, in addition to the This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
psychiatric manifestations of early and untreated GD (9), the condition is also associated with a diagnosis of psychiatric disorders (anxiety disorders, depression and psychoses) in the long-term, all of which lead to excess mortality (2) . Based on the aforementioned, accepting that our study does not prove causality, we consider our findings plausible. Also the strong association of GO with deaths from suicide can intuitively be understood, in view of the huge impact of GO on quality of life, appearance, work disability, and early retirement (8, 10, 11).
Classification of the thyroid diagnosis of GD may be inaccurate. However, as mentioned previously, it has been shown that misclassification occurs in less than 2% (20, 21 ). Undoubtedly, not all GO cases were classified as such. But it has been shown that the cases with moderate to severe GO are correctly classified (38). It is generally accepted that the quality and validity of register-based data on somatic and psychiatric diagnoses are reliable (19, 22) . Although our study is nationwide, the data is based on rather crude register-based material, and we lack information about life-style, smoking, and drinking habits. Thus we are unable to further disentangle the relative importance of these confounders. It is also important to point out that our control population only includes individuals who during the study period had at least one in-or outpatient contact.
Accepting that these individuals may have an increased risk of unnatural death as compared to the general background population, our results may in fact underestimate the risk for unnatural death in GD.
We conclude that mortality by suicide seems to be increased in GD, most significantly in patients with GO. In addition to independent confirmation of our data, This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
